Protosappanin A protects against experimental autoimmune myocarditis, and induces metabolically reprogrammed tolerogenic DCs (vol 146, 104269, 2019)

Wu, J; Liu, MY; Mang, G; Yu, S; Chen, Q; Li, TT; Wang, YC; Meng, Y; Tang, XY; Zheng, Y; Sun, Y; Zhang, MM; Yu, B

PHARMACOLOGICAL RESEARCH, 2020; 160 ():